HomeRPTX • NASDAQ
add
Repare Therapeutics Inc
Previous close
$2.23
Day range
$2.20 - $2.23
Year range
$0.89 - $4.07
Market cap
95.21M USD
Avg Volume
846.97K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 11.62M | — |
Operating expense | 4.55M | -29.42% |
Net income | 3.26M | 109.47% |
Net profit margin | 28.04 | — |
Earnings per share | — | — |
EBITDA | -358.00K | 98.96% |
Effective tax rate | 4.26% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 112.60M | -37.24% |
Total assets | 126.75M | -38.59% |
Total liabilities | 11.62M | -63.03% |
Total equity | 115.13M | — |
Shares outstanding | 42.99M | — |
Price to book | 0.83 | — |
Return on assets | -0.84% | — |
Return on capital | -0.95% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 3.26M | 109.47% |
Cash from operations | 2.65M | 108.68% |
Cash from investing | 2.54M | -91.84% |
Cash from financing | 30.00K | -81.93% |
Net change in cash | 5.17M | 616.92% |
Free cash flow | -2.68M | 84.42% |
About
Founded
2016
Website
Employees
129